TipRanks
Novartis AG (MX:NOVNN)
:NOVNN
Mexico Market
NOVNN
Novartis AG
RESEARCH TOOLSreports

Novartis AG (NOVNN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

NOVNN Analyst Ratings

Hold
16Ratings
Hold
4 Buy
11 Hold
1 Sell
Based on 16 analysts giving stock ratings to
Novartis
AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NOVNN Stock 12 Month Forecast

Average Price Target

$2,658.79
▲(2.17% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for Novartis AG in the last 3 months. The average price target is $2,658.79 with a high forecast of $3,192.51 and a low forecast of $2,234.76. The average price target represents a 2.17% change from the last price of $2,602.21.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2186":"$2,186","3193":"$3,193","2437.75":"$2,437.8","2689.5":"$2,689.5","2941.25":"$2,941.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3192.508248,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.19K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2658.786356283077,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.66K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2234.7557736,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.23K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2186,2437.75,2689.5,2941.25,3193],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2602.21,2647.6175575384614,2693.025115076923,2738.4326726153845,2783.8402301538463,2829.2477876923076,2874.6553452307694,2920.0629027692307,2965.4704603076925,3010.878017846154,3056.2855753846156,3101.693132923077,3147.1006904615388,{"y":3192.508248,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2602.21,2606.5620274063904,2610.914054812781,2615.2660822191715,2619.6181096255623,2623.9701370319526,2628.3221644383434,2632.6741918447337,2637.0262192511245,2641.378246657515,2645.7302740639057,2650.082301470296,2654.434328876687,{"y":2658.786356283077,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2602.21,2573.9442902769233,2545.678580553846,2517.4128708307694,2489.147161107692,2460.8814513846155,2432.6157416615383,2404.3500319384616,2376.0843222153844,2347.8186124923077,2319.5529027692305,2291.287193046154,2263.0214833230766,{"y":2234.7557736,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2290.433,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2187.903,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2187.903,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2305.316,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2364.342,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2505.732,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2832.559,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2759.31,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2567.24,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2487.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2487.4,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2753.91,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2602.21,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$3,193Average Price Target$2,659Lowest Price Target$2,235
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on MX:NOVNN
Sachin Jain
Bank of America Securities
Bank of America Securities
$3,192.51
Buy
22.68%
Upside
Reiterated
09/23/26
Buy Rating Reiterated on Novartis as Diversified Pipeline Supports Medium-Term Growth; CHF 150 Price Target Unchanged
Goldman Sachs Analyst forecast on MX:NOVNN
James Quigley
Goldman Sachs
Goldman Sachs
$2,405.02→$2,341.17
Sell
-10.03%
Downside
Reiterated
09/22/26
Goldman Sachs Keeps Their Sell Rating on Novartis AG (NOVN)
UBS Analyst forecast on MX:NOVNN
Matthew Weston
UBS
UBS
―
Hold
―
Reiterated
09/17/26
Novartis AG (NOVN) Receives a Hold from UBS
Deutsche Bank Analyst forecast on MX:NOVNN
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
$2,554.01
Hold
-1.85%
Downside
Reiterated
09/15/26
Deutsche Bank Sticks to Its Hold Rating for Novartis AG (NOVN)
RBC Capital Analyst forecast on MX:NOVNN
Trung Huynh
RBC Capital
RBC Capital
$2,554.01
Hold
-1.85%
Downside
Reiterated
09/14/26
RBC Capital Keeps Their Hold Rating on Novartis AG (NOVN)
Berenberg Bank Analyst forecast on MX:NOVNN
Kerry Holford
Berenberg Bank
Berenberg Bank
$2,554.01→$2,234.76
Hold
-14.12%
Downside
Reiterated
09/11/26
Novartis AG (NOVN) Gets a Hold from Berenberg Bank
HSBC Analyst forecast on MX:NOVNN
Rajesh Kumar
HSBC
HSBC
$2,341.17
Hold
-10.03%
Downside
Upgraded
09/09/26
Novartis upgraded to Hold from Reduce at HSBCNovartis upgraded to Hold from Reduce at HSBC
Citi Analyst forecast on MX:NOVNN
Graham Parry
Citi
Citi
$3,022.24→$2,873.26
Buy
10.42%
Upside
Reiterated
09/09/26
Novartis AG (NOVN) Gets a Buy from Citi
Barclays Analyst forecast on MX:NOVNN
James Gordon CFA
Barclays
Barclays
$2,660.42→$2,766.84
Hold
6.33%
Upside
Reiterated
09/08/26
Novartis AG (NOVN) Gets a Hold from Barclays
J.P. Morgan Analyst forecast on MX:NOVNN
Richard Vosser
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
09/07/26
Novartis AG (NOVN) Gets a Buy from J.P. Morgan
Jefferies Analyst forecast on MX:NOVNN
Michael Leuchten
Jefferies
Jefferies
$2,341.17
Hold
-10.03%
Downside
Reiterated
09/07/26
Jefferies Reaffirms Their Hold Rating on Novartis AG (NOVN)
Bank Vontobel Analyst forecast on MX:NOVNN
Unknown Analyst
Bank Vontobel
Not Ranked
Bank Vontobel
$2,766.84→$2,724.27
Hold
4.69%
Upside
Reiterated
09/07/26
Bank Vontobel Reaffirms Their Hold Rating on Novartis AG (NOVN)
Morgan Stanley Analyst forecast on MX:NOVNN
Thibault Boutherin
Morgan Stanley
Morgan Stanley
$2,873.26
Buy
10.42%
Upside
Reiterated
09/01/26
Novartis Maintained at Buy as Strong Remibrutinib Phase 3 Data Support RMS Opportunity; $135 Price Target Unchanged
TD Cowen Analyst forecast on MX:NOVNN
Shelby Tucker
TD Cowen
TD Cowen
$2,937.11
Hold
12.87%
Upside
Reiterated
07/27/26
Novartis: Solid Fundamentals but Balanced Risk-Reward Justify Hold Rating
Bernstein Analyst forecast on MX:NOVNN
Justin Smith
Bernstein
Bernstein
$2,660.42→$2,830.69
Hold
8.78%
Upside
Assigned
07/22/26
Novartis AG (NOVN) Receives a Hold from Bernstein
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on MX:NOVNN
Sachin Jain
Bank of America Securities
Bank of America Securities
$3,192.51
Buy
22.68%
Upside
Reiterated
09/23/26
Buy Rating Reiterated on Novartis as Diversified Pipeline Supports Medium-Term Growth; CHF 150 Price Target Unchanged
Goldman Sachs Analyst forecast on MX:NOVNN
James Quigley
Goldman Sachs
Goldman Sachs
$2,405.02→$2,341.17
Sell
-10.03%
Downside
Reiterated
09/22/26
Goldman Sachs Keeps Their Sell Rating on Novartis AG (NOVN)
UBS Analyst forecast on MX:NOVNN
Matthew Weston
UBS
UBS
―
Hold
―
Reiterated
09/17/26
Novartis AG (NOVN) Receives a Hold from UBS
Deutsche Bank Analyst forecast on MX:NOVNN
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
$2,554.01
Hold
-1.85%
Downside
Reiterated
09/15/26
Deutsche Bank Sticks to Its Hold Rating for Novartis AG (NOVN)
RBC Capital Analyst forecast on MX:NOVNN
Trung Huynh
RBC Capital
RBC Capital
$2,554.01
Hold
-1.85%
Downside
Reiterated
09/14/26
RBC Capital Keeps Their Hold Rating on Novartis AG (NOVN)
Berenberg Bank Analyst forecast on MX:NOVNN
Kerry Holford
Berenberg Bank
Berenberg Bank
$2,554.01→$2,234.76
Hold
-14.12%
Downside
Reiterated
09/11/26
Novartis AG (NOVN) Gets a Hold from Berenberg Bank
HSBC Analyst forecast on MX:NOVNN
Rajesh Kumar
HSBC
HSBC
$2,341.17
Hold
-10.03%
Downside
Upgraded
09/09/26
Novartis upgraded to Hold from Reduce at HSBCNovartis upgraded to Hold from Reduce at HSBC
Citi Analyst forecast on MX:NOVNN
Graham Parry
Citi
Citi
$3,022.24→$2,873.26
Buy
10.42%
Upside
Reiterated
09/09/26
Novartis AG (NOVN) Gets a Buy from Citi
Barclays Analyst forecast on MX:NOVNN
James Gordon CFA
Barclays
Barclays
$2,660.42→$2,766.84
Hold
6.33%
Upside
Reiterated
09/08/26
Novartis AG (NOVN) Gets a Hold from Barclays
J.P. Morgan Analyst forecast on MX:NOVNN
Richard Vosser
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
09/07/26
Novartis AG (NOVN) Gets a Buy from J.P. Morgan
Jefferies Analyst forecast on MX:NOVNN
Michael Leuchten
Jefferies
Jefferies
$2,341.17
Hold
-10.03%
Downside
Reiterated
09/07/26
Jefferies Reaffirms Their Hold Rating on Novartis AG (NOVN)
Bank Vontobel Analyst forecast on MX:NOVNN
Unknown Analyst
Bank Vontobel
Not Ranked
Bank Vontobel
$2,766.84→$2,724.27
Hold
4.69%
Upside
Reiterated
09/07/26
Bank Vontobel Reaffirms Their Hold Rating on Novartis AG (NOVN)
Morgan Stanley Analyst forecast on MX:NOVNN
Thibault Boutherin
Morgan Stanley
Morgan Stanley
$2,873.26
Buy
10.42%
Upside
Reiterated
09/01/26
Novartis Maintained at Buy as Strong Remibrutinib Phase 3 Data Support RMS Opportunity; $135 Price Target Unchanged
TD Cowen Analyst forecast on MX:NOVNN
Shelby Tucker
TD Cowen
TD Cowen
$2,937.11
Hold
12.87%
Upside
Reiterated
07/27/26
Novartis: Solid Fundamentals but Balanced Risk-Reward Justify Hold Rating
Bernstein Analyst forecast on MX:NOVNN
Justin Smith
Bernstein
Bernstein
$2,660.42→$2,830.69
Hold
8.78%
Upside
Assigned
07/22/26
Novartis AG (NOVN) Receives a Hold from Bernstein
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novartis AG

3 Months
David EvansKepler Capital
Success Rate
23/31 ratings generated profit
74%
Average Return
+4.10%
Copying David Evans's trades and holding each position for 3 Months would result in 74.19% of your transactions generating a profit, with an average return of +4.10% per trade.
1 Year
David EvansKepler Capital
Success Rate
30/31 ratings generated profit
97%
Average Return
+14.26%
Copying David Evans's trades and holding each position for 1 Year would result in 96.77% of your transactions generating a profit, with an average return of +14.26% per trade.
2 Years
David EvansKepler Capital
Success Rate
30/31 ratings generated profit
97%
Average Return
+25.54%
Copying David Evans's trades and holding each position for 2 Years would result in 96.77% of your transactions generating a profit, with an average return of +25.54% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NOVNN Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
22
20
20
18
19
Hold
11
12
14
13
21
Sell
5
2
2
2
2
Strong Sell
0
0
0
0
0
total
38
34
36
33
42
In the current month, NOVNN has received 19 Buy Ratings, 21 Hold Ratings, and 2 Sell Ratings. NOVNN average Analyst price target in the past 3 months is 2,658.79.
Each month's total comprises the sum of three months' worth of ratings.

NOVNN Financial Forecast

NOVNN Earnings Forecast

Next quarter’s earnings estimate for NOVNN is $38.77 with a range of $35.53 to $41.35. The previous quarter’s EPS was $41.35. NOVNN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year NOVNN has Performed in-line its overall industry.
Next quarter’s earnings estimate for NOVNN is $38.77 with a range of $35.53 to $41.35. The previous quarter’s EPS was $41.35. NOVNN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year NOVNN has Performed in-line its overall industry.

NOVNN Sales Forecast

Next quarter’s sales forecast for NOVNN is $250.87B with a range of $245.77B to $255.64B. The previous quarter’s sales results were $236.94B. NOVNN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year NOVNN has Performed in-line its overall industry.
Next quarter’s sales forecast for NOVNN is $250.87B with a range of $245.77B to $255.64B. The previous quarter’s sales results were $236.94B. NOVNN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year NOVNN has Performed in-line its overall industry.

NOVNN Stock Forecast FAQ

What is MX:NOVNN’s average 12-month price target, according to analysts?
Based on analyst ratings, Novartis AG’s 12-month average price target is 2,658.79.
    What is MX:NOVNN’s upside potential, based on the analysts’ average price target?
    Novartis AG has 2.17% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Novartis AG a Buy, Sell or Hold?
          Novartis AG has a consensus rating of Hold, which is based on 4 buy ratings, 11 hold ratings and 1 sell ratings.
            What is Novartis AG’s share price target?
            The average share price target for Novartis AG is 2,658.79. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $3,192.51 ,and the lowest forecast is $2,234.76. The average share price target represents 2.17% Increase from the current price of $2,602.21.
              What do analysts say about Novartis AG?
              Novartis AG’s analyst rating consensus is a Hold. This is based on the ratings of 16 Wall Streets Analysts.
                How can I buy shares of Novartis AG?
                To buy shares of MX:NOVNN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.